99 related articles for article (PubMed ID: 26937629)
1. MicroRNA-3666 Regulates Thyroid Carcinoma Cell Proliferation via MET.
Wang G; Cai C; Chen L
Cell Physiol Biochem; 2016; 38(3):1030-9. PubMed ID: 26937629
[TBL] [Abstract][Full Text] [Related]
2. Regulation of MET-mediated proliferation of thyroid carcinoma cells by miR-449b.
Chen L; Xu L; Wang G
Tumour Biol; 2015 Nov; 36(11):8653-60. PubMed ID: 26044563
[TBL] [Abstract][Full Text] [Related]
3. Restoration of microRNA-373 suppresses growth of human T-cell lymphoma cells by repressing CCND1.
Tian YY; Jia CM; Li Y; Wang Y; Jiang L; Liu AC
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4435-4444. PubMed ID: 27874957
[TBL] [Abstract][Full Text] [Related]
4. MiR-449c inhibits gastric carcinoma growth.
Wu Z; Wang H; Fang S; Xu C
Life Sci; 2015 Sep; 137():14-9. PubMed ID: 26141986
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
7. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
8. MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2.
Zhu P; Zhang J; Zhu J; Shi J; Zhu Q; Gao Y
Cell Physiol Biochem; 2015; 37(4):1572-80. PubMed ID: 26513239
[TBL] [Abstract][Full Text] [Related]
9. MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression.
Lei ST; Shen F; Chen JW; Feng JH; Cai WS; Shen L; Hu ZW; Xu B
Biomed Pharmacother; 2016 Dec; 84():1834-1840. PubMed ID: 27829546
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG8 participates in the development of endometrial carcinoma through regulating c-MET expression by miR-152.
Yang CH; Zhang XY; Zhou LN; Wan Y; Song LL; Gu WL; Liu R; Ma YN; Meng HR; Tian YL; Zhang Y
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1629-1637. PubMed ID: 29630089
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
12. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
Huang P; Mao LF; Zhang ZP; Lv WW; Feng XP; Liao HJ; Dong C; Kaluba B; Tang XF; Chang S
Thyroid; 2018 May; 28(5):613-623. PubMed ID: 29634399
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1280 modulates cell growth and invasion of thyroid carcinoma through targeting estrogen receptor α.
Meng D; Li Z; Ma X; Fu L; Qin G
Cell Mol Biol (Noisy-le-grand); 2016 Mar; 62(3):1-6. PubMed ID: 27064865
[TBL] [Abstract][Full Text] [Related]
14. MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3'-UTR.
Zhao X; Sun Z; Li H; Jiang F; Zhou J; Zhang L
Cancer Biomark; 2017 Aug; 20(2):207-216. PubMed ID: 28869452
[TBL] [Abstract][Full Text] [Related]
15. miR-196a-2 Promotes Malignant Progression of Thyroid Carcinoma by Targeting NRXN1.
Fan Y; Fei M; Li Y; Gao Z; Zhu Y; Dai G; Wu D
Comput Math Methods Med; 2021; 2021():4856820. PubMed ID: 34158819
[TBL] [Abstract][Full Text] [Related]
16. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
17. MiR-410 regulates MET to influence the proliferation and invasion of glioma.
Chen L; Zhang J; Feng Y; Li R; Sun X; Du W; Piao X; Wang H; Yang D; Sun Y; Li X; Jiang T; Kang C; Li Y; Jiang C
Int J Biochem Cell Biol; 2012 Nov; 44(11):1711-7. PubMed ID: 22750473
[TBL] [Abstract][Full Text] [Related]
18. Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met.
Cai KM; Bao XL; Kong XH; Jinag W; Mao MR; Chu JS; Huang YJ; Zhao XJ
Int J Mol Med; 2010 Apr; 25(4):565-71. PubMed ID: 20198305
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
Hu Z; Lin Y; Chen H; Mao Y; Wu J; Zhu Y; Xu X; Xu X; Li S; Zheng X; Xie L
Biochem Biophys Res Commun; 2013 May; 435(1):82-7. PubMed ID: 23618864
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
